pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium

Poly(lactic-co-glycolic acid) (PLGA) based nanoparticles have gained increasing attention in delivery applications due to their capability for controlled drug release characteristics, biocompatibility, and tunable mechanical, as well as degradation, properties. However, thorough study is always required while evaluating potential toxicity of the particles from dose dumping, inconsistent release and drug-polymer interactions. In this research, we developed PLGA nanoparticles modified by chitosan (CS), a cationic and pH responsive polysaccharide that bears repetitive amine groups in its backbone. We used a model drug, diclofenac sodium (DS), a nonsteroidal anti-inflammatory drug (NSAID), to study the drug loading and release characteristics. PLGA nanoparticles were synthesized by double-emulsion solvent evaporation technique. The nanoparticles were evaluated based on their particle size, surface charge, entrapment efficacy, and effect of pH in drug release profile. About 390–420 nm of average diameters and uniform morphology of the particles were confirmed by scanning electron microscope (SEM) imaging and dynamic light scattering (DLS) measurement. Chitosan coating over PLGA surface was confirmed by FTIR and DLS. Drug entrapment efficacy was up to 52%. Chitosan coated PLGA showed a pH responsive drug release in in vitro. The release was about 45% more at pH 5.5 than at pH 7.4. The results of our study indicated the development of chitosan coating over PLGA nanoparticle for pH dependent controlled release DS drug for therapeutic applications.

[1]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[3]  J. Vane,et al.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Parveen,et al.  Polymeric nanoparticles for cancer therapy. , 2008, Journal of drug targeting.

[5]  M. R. Kumar,et al.  PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[7]  A. Ludwig,et al.  The use of mucoadhesive polymers in ocular drug delivery. , 2005, Advanced drug delivery reviews.

[8]  M. Alonso,et al.  Design of microencapsulated chitosan microspheres for colonic drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Maria Angela Vandelli,et al.  Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. , 2006, Biomaterials.

[10]  C. Cametti,et al.  Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. , 2013, Colloids and surfaces. B, Biointerfaces.

[11]  Joonyoung Park,et al.  Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. , 2012, Molecular pharmaceutics.

[12]  D. S. Giordani,et al.  Chitosan/siloxane hybrid polymer: synthesis, characterization and performance as a support for immobilizing enzyme , 2011 .

[13]  J. Suh,et al.  Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. , 2000, Biomaterials.

[14]  R. Bodmeier,et al.  A Novel Approach to the Oral Delivery of Micro- or Nanoparticles , 1989, Pharmaceutical Research.

[15]  A. Madhusudhan,et al.  Efficient pH Dependent Drug Delivery to Target Cancer Cells by Gold Nanoparticles Capped with Carboxymethyl Chitosan , 2014, International journal of molecular sciences.

[16]  R. Sirianni,et al.  PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS , 2013, Journal of visualized experiments : JoVE.

[17]  Nava P. Rijal,et al.  Fabrication and Characterization of Electrospun PCL-MgO-Keratin-Based Composite Nanofibers for Biomedical Applications , 2015, Materials.

[18]  S. Cui,et al.  Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine , 2014, International journal of nanomedicine.

[19]  Claus-Michael Lehr,et al.  Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[20]  T. Maekawa,et al.  Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease , 2012, PloS one.

[21]  M. Ercan,et al.  Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. , 2000, International journal of pharmaceutics.

[22]  S. Ostad,et al.  Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. , 2008, Journal of drug targeting.

[23]  Anil Mahapatro,et al.  Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines , 2011, Journal of nanobiotechnology.

[24]  R. Poppi,et al.  Direct determination of diclofenac in pharmaceutical formulations containing B vitamins by using UV spectrophotometry and partial least squares regression. , 2004, Journal of pharmaceutical and biomedical analysis.

[25]  V. Dodane,et al.  Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.

[26]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[27]  Shantikumar V. Nair,et al.  Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications , 2010 .

[28]  S. Jain,et al.  Design and Optimization of Diclofenac Sodium Controlled Release Solid Dispersions by Response Surface Methodology , 2022 .

[29]  Shuai Shi,et al.  Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac , 2015, Scientific Reports.

[30]  E. Jäger,et al.  Effects of indomethacin‐loaded nanocapsules in experimental models of inflammation in rats , 2009, British journal of pharmacology.

[31]  K. Janes,et al.  Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.

[32]  M. R. Ravi Kumar,et al.  Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone® , 2009, Pharmaceutical Research.

[33]  Steven J Siegel,et al.  Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. , 2008, International journal of pharmaceutics.

[34]  S. Mendoza,et al.  Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles , 2012 .

[35]  Jun Wang,et al.  Delivery systems for siRNA drug development in cancer therapy , 2015 .

[36]  Asgar Ali,et al.  Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[37]  Lingxue Kong,et al.  Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery , 2013, AAPS PharmSciTech.